Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
126 participants
INTERVENTIONAL
2003-09-30
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will investigate the benefits of CHESS, a Human Cancer Mentor and the potential additional benefit of combining CHESS and a Cancer Mentor compared to Internet access for women diagnosed with breast cancer. Our goal is to advance interactive cancer communication systems, thus improving quality of life for patients and families facing cancer, especially underserved populations.
Primary Aims:
* Determine if the Internet, CHESS, a Cancer Mentor, or a combination of CHESS and the Cancer Mentor improve quality of life for women with breast cancer
* Determine which of the above conditions is most effective
* Determine which of the above conditions is most cost efficient
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Component and Couple Analysis of Cancer Communications
NCT00468741
CHESS: Human and Computer Mentors for Prostate Cancer Patients
NCT00516256
Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers
NCT00365963
CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer
NCT00214162
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
NCT06860425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CHESS Condition
Subjects who receive the CHESS (Comprehensive Health Enhancement Support System)
CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor
computer based education and support
Mentor Condition
Subjects who receive access to a Human Cancer Mentor only
CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor
computer based education and support
CHESS + Mentor
Subjects who receive the CHESS system plus a Human Cancer Mentor
CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor
computer based education and support
Internet Only
Subjects receive routine care and nothing else
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor
computer based education and support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All subjects must be within 2 months of their primary breast cancer diagnosis,
* All subjects must be at least 18 years of age,
* All subjects must be able to read and write English at the 6th-grade level
* Not homeless
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Hawkins, PhD.
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hartford Hospital
Hartford, Connecticut, United States
M.D. Anderson
Houston, Texas, United States
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1P50CA09817-01A1
Identifier Type: -
Identifier Source: secondary_id
2003-192
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.